These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36920728)

  • 21. CHSY1 promotes CD8
    Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
    J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precursor exhausted CD8
    Huang H; Ge J; Fang Z; Wu S; Jiang H; Lang Y; Chen J; Xiao W; Xu B; Liu Y; Chen L; Zheng X; Jiang J
    Front Immunol; 2024; 15():1362140. PubMed ID: 38510246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCL8 induces M2 macrophage polarization and inhibits CD8
    Shao Y; Lan Y; Chai X; Gao S; Zheng J; Huang R; Shi Y; Xiang Y; Guo H; Xi Y; Yang L; Yang T
    FASEB J; 2023 Oct; 37(10):e23173. PubMed ID: 37665572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development.
    Katkeviciute E; Hering L; Montalban-Arques A; Busenhart P; Schwarzfischer M; Manzini R; Conde J; Atrott K; Lang S; Rogler G; Naschberger E; Schellerer VS; Stürzl M; Rickenbacher A; Turina M; Weber A; Leibl S; Leventhal GE; Levesque M; Boyman O; Scharl M; Spalinger MR
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33001862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colon-specific immune microenvironment regulates cancer progression versus rejection.
    Trimaglio G; Tilkin-Mariamé AF; Feliu V; Lauzéral-Vizcaino F; Tosolini M; Valle C; Ayyoub M; Neyrolles O; Vergnolle N; Rombouts Y; Devaud C
    Oncoimmunology; 2020 Jul; 9(1):1790125. PubMed ID: 32923152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. m
    Wang L; Hui H; Agrawal K; Kang Y; Li N; Tang R; Yuan J; Rana TM
    EMBO J; 2020 Oct; 39(20):e104514. PubMed ID: 32964498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of zinc carnosine in the treatment of colorectal cancer and its potential in combination with immunotherapy
    Tang W; Liu H; Li X; Ooi TC; Rajab NF; Cao H; Sharif R
    Aging (Albany NY); 2022 Nov; 14(21):8688-8699. PubMed ID: 36375474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MGP promotes CD8
    Rong D; Sun G; Zheng Z; Liu L; Chen X; Wu F; Gu Y; Dai Y; Zhong W; Hao X; Zhang C; Pan X; Tang J; Tang W; Wang X
    Int J Biol Sci; 2022; 18(6):2345-2361. PubMed ID: 35414780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors.
    Yi M; Niu M; Wu Y; Ge H; Jiao D; Zhu S; Zhang J; Yan Y; Zhou P; Chu Q; Wu K
    J Hematol Oncol; 2022 Oct; 15(1):142. PubMed ID: 36209176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4
    Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncolytic adenovirus H101 ameliorate the efficacy of anti-PD-1 monotherapy in colorectal cancer.
    Huang L; Zhao H; Shan M; Chen H; Xu B; He Y; Zhao Y; Liu Z; Chen J; Xu Q
    Cancer Med; 2022 Dec; 11(23):4575-4587. PubMed ID: 35762456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BRAF D594A mutation defines a unique biological and immuno-modulatory subgroup associated with functional CD8
    Li W; Zhao C; Li W; Gong Y; Ma K; Lu Y; Liu X; Zhang L; Guo F
    J Transl Med; 2023 Oct; 21(1):737. PubMed ID: 37853469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. scRNA-seq of colorectal cancer shows regional immune atlas with the function of CD20
    Ji L; Fu G; Huang M; Kao X; Zhu J; Dai Z; Chen Y; Li H; Zhou J; Chu X; Lei Z
    Cancer Lett; 2024 Mar; 584():216664. PubMed ID: 38253219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma.
    Liang Z; Sun R; Tu P; Liang Y; Liang L; Liu F; Bian Y; Yin G; Zhao F; Jiang M; Gu J; Tang D
    Front Immunol; 2022; 13():944286. PubMed ID: 36591255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MAP7D2 reduces CD8
    Wu Q; Yue X; Liu H; Zhu Y; Ke H; Yang X; Yin S; Li Z; Zhang Y; Hu T; Lan P; Wu X
    Mol Ther; 2023 Jan; 31(1):90-104. PubMed ID: 36081350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A humanized 4-1BB-targeting agonistic antibody exerts potent antitumor activity in colorectal cancer without systemic toxicity.
    Cheng LS; Cheng YF; Liu WT; Shen A; Zhang D; Xu T; Yin W; Cheng M; Ma X; Wang F; Zhao Q; Zeng X; Zhang Y; Shen G
    J Transl Med; 2022 Sep; 20(1):415. PubMed ID: 36076251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein L3 enhances CD8+ T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis.
    Lv Y; Tang W; Xu Y; Chang W; Zhang Z; Lin Q; Ji M; Feng Q; He G; Xu J
    Int J Biol Sci; 2023; 19(4):1284-1298. PubMed ID: 36923931
    [No Abstract]   [Full Text] [Related]  

  • 40. ID1 expressing macrophages support cancer cell stemness and limit CD8
    Shang S; Yang C; Chen F; Xiang RS; Zhang H; Dai SY; Liu J; Lv XX; Zhang C; Liu XT; Zhang Q; Lu SB; Song JW; Yu JJ; Zhou JC; Zhang XW; Cui B; Li PP; Zhu ST; Zhang HZ; Hua F
    Nat Commun; 2023 Nov; 14(1):7661. PubMed ID: 37996458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.